Analysts’ Updated EPS Estimates for November 19th (ATNM, BNS, BRBR, DTC, DY, ENPH, ETG, KBR, NTLA, OCSL)

Analysts’ updated eps estimates for Tuesday, November 19th: Actinium Pharmaceuticals (NYSE:ATNM) had its overweight rating reiterated by analysts at Stephens. The firm currently has a $5.00 price target on the stock. Bank of Nova Scotia (TSE:BNS) (NYSE:BNS) was upgraded by analysts at Canaccord Genuity Group Inc. from a hold rating to a buy rating. Canaccord […]

Leave a Reply

Your email address will not be published.

Previous post Bank Hapoalim B.M. (OTCMKTS:BKHYY) Reaches New 12-Month High – What’s Next?
Next post Intellia Therapeutics’ (NTLA) Buy Rating Reaffirmed at Canaccord Genuity Group